Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,05 USD | +6,64% | -1,93% | -51,39% |
20/03 | T2 Biosystems, Inc. Herhaalt de omzetbegeleiding voor het jaar 2024 | CI |
20/03 | Transcript : T2 Biosystems, Inc. - Special Call |
Omzet 2021 | 28,06 mln. 25,98 mln. | Omzet 2022 | 22,3 mln. 20,65 mln. | Marktkapitalisatie | 10,39 mln. 9,62 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -49 mln. -45,37 mln. | Nettowinst (verlies) 2022 | -62 mln. -57,41 mln. | EV/omzet 2021 | 3,98 x |
Nettoschuld 2021 | 26,08 mln. 24,15 mln. | Nettoschuld 2022 | 48,89 mln. 45,27 mln. | EV/omzet 2022 | 2,66 x |
K/w-verhouding 2021 |
-1,67
x | K/w-verhouding 2022 |
-0,12
x | Werknemers | 158 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 75,74% |
Recentste transcriptie over T2 Biosystems, Inc.
1 dag | +6,64% | ||
1 week | -1,93% | ||
Lopende maand | -39,48% | ||
1 maand | -42,45% | ||
3 maanden | -40,89% | ||
6 maanden | -83,14% | ||
Lopend jaar | -51,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 08-01-20 |
John Sprague
DFI | Director of Finance/CFO | 65 | 30-01-18 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 74 | 01-07-14 |
Seymour Liebman
BRD | Director/Board Member | 74 | 21-09-16 |
Robin Toft
BRD | Director/Board Member | 63 | 14-06-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 3,05 | +6,64% | 273 914 |
26-03-24 | 2,86 | -4,03% | 189 709 |
25-03-24 | 2,98 | +3,83% | 252 308 |
22-03-24 | 2,87 | -4,97% | 351 779 |
21-03-24 | 3,02 | -2,89% | 321 150 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-51,39% | 15,04 mln. | |
+9,15% | 221 mld. | |
+7,53% | 184 mld. | |
+18,60% | 142 mld. | |
+18,70% | 101 mld. | |
+8,10% | 68,07 mld. | |
+24,79% | 57,27 mld. | |
-2,49% | 47,42 mld. | |
+6,00% | 43,19 mld. | |
+14,13% | 28,84 mld. |